Shui Long Wang

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 9 EPO patents. Top assignees: Nestec S.a., Prometheus Biosciences, Inc., Prometheus Laboratories Inc.. Active years: 2012-2020.

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 91.7

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 51(Granted Patents)

Company Filing History:

Prometheus Biosciences, Inc.

patents

1 out of 22

Prometheus Laboratories Inc.

patents

Years Active: 2012-2020

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10794906 - Assays for detecting neutralizing autoantibodies to biologic therapy (2020-10-06),

2. 10036757 - Addressable antibody arrays and methods of use (2018-07-31),

3. 9784748 - Methods for determining anti-drug antibody isotypes (2017-10-10),

4. 9506920 - Assays for the detection of anti-TNF drugs and autoantibodies (2016-11-29),

5. 9482672 - Methods for diagnosing irritable bowel syndrome (2016-11-01),

6. 9465027 - Assays for detecting neutralizing autoantibodies to biologic therapy (2016-10-11),

7. 8865417 - Assays for the detection of anti-TNF drugs and autoantibodies (2014-10-21),

8. 8709733 - Methods for diagnosing irritable bowel syndrome (2014-04-29),

9. 8574855 - Assays for the detection of anti-TNF drugs and autoantibodies (2013-11-05),

10. 8519096 - Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis (2013-08-27),

11. 8278057 - Addressable antibody arrays and methods of use (2012-10-02),

12. 8114616 - Methods for diagnosing irritable bowel syndrome (2012-02-14),

Title: Innovations and Contributions of Shui Long Wang

Introduction

Shui Long Wang is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of assays for detecting autoantibodies related to biologic therapies. With a total of 12 patents, his work has had a substantial impact on therapeutic monitoring and treatment optimization.

Latest Patents

One of his latest patents is titled "Assays for detecting neutralizing autoantibodies to biologic therapy." This invention provides assays for detecting and measuring the presence or level of neutralizing and non-neutralizing autoantibodies to biologics, such as anti-TNFα drug therapeutics. The invention is useful for monitoring the formation of these antibodies over time while a subject is undergoing biologic therapy. It also aids in predicting the cross-reactivity of neutralizing anti-drug antibodies with alternative biologic therapies, thereby guiding treatment decisions and improving therapeutic outcomes.

Another notable patent is "Addressable antibody arrays and methods of use." This patent discloses systems and assay methods for detecting autoantibodies in a sample. The methods utilize a mass tag that is releasably connected to an antigen, which can be detected by mass spectrometry or fluorescence. This innovation has applications in diagnosing diseases or disorders in subjects.

Career Highlights

Shui Long Wang has worked with several notable companies, including Nestec S.A. and Prometheus Laboratories Inc. His experience in these organizations has allowed him to refine his expertise in biotechnology and patent development.

Collaborations

Throughout his career, Wang has collaborated with various professionals, including Sharat Singh and Linda Ohrmund. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Shui Long Wang's contributions to biotechnology through his patents and collaborations have significantly advanced the field of therapeutic monitoring. His work continues to influence treatment strategies and improve patient outcomes in biologic therapies.